Jared Whitlock

Reporter

Email: jwhitlock@sdbj.com
Phone: 858-634-4636 Extension: 3130

Recent Stories

Gossamer Lures Former Bristol-Myers Squibb Executive as CSO

San Diego-based Gossamer Bio, which in July snagged a $230 million series B round, recently announced the hire of a former executive from pharmaceutical giant Bristol-Myers Squibb.

Life Sciences Reporter's Notebook: Some Biotechs Find Freedom in Self-Commercialization Model

Not many biotechs in San Diego both develop drugs and commercialize them.

Tease photo

$65M Pledged for Drug Development Partnership with UC San Diego

A New York investment management firm has pledged $65 million to a new venture with UC San Diego to bridge the divide between basic research and clinical trials.

Executive Q & A: Dr. Patricio Frias, Rady Children’s Hospital

Dr. Patricio “Patrick” A. Frias’ is a physician-turned-executive, a path that helped land a new gig as the president and CEO of Rady Children’s Hospital and Health Center.

Tease photo

Inscripta Acquires Solana Biosciences

Inscripta has purchased Solana Biosciences, a San Diego company led by former Illumina veterans that specializes in genomics manufacturing operations.

ResMed Files Patent Infringement Petition Against Fisher & Paykel

San Diego-based ResMed has filed a patent infringement petition that is seeking to ban the U.S. import and sale of select breathing masks from New Zealand-based Fisher & Paykel.

IPO Puts Crinetics In Position to Compete

BIOTECH: Oral Drug Replaces Shot, Aims for Greater Efficacy

After early years operating on a shoestring budget, Crinetics Pharmaceuticals is flush with cash to pursue ambitious drug development plans.

Tease photo

Ionis Feels Effect of FDA’s Ruling

The U.S. Food and Drug Administration on Aug. 26 declined to approve Waylivra, a drug from Ionis Pharmaceuticals targeting an ultra-rare disease.

Illumina System Gains Approval in China

Illumina notched approval from the China National Drug Administration to market and sell its MiSeqDx sequencing system to hospitals and other medical institutions throughout the country.

Biotechs Find Favorable Conditions in UTC As An Amenity-Rich Alternative to Torrey Pines

When scouting where to consolidate San Diego operations, Takeda Pharmaceuticals put together a checklist. Most pressing: a plot that could accommodate 300 employees, near research institutions and other life science companies.

Tease photo

Ionis Pharmaceuticals’ Stock Drops After FDA Letter

Shares of Ionis Pharmaceuticals and spinout Akcea Therapeutics kept falling Tuesday morning after a U.S. Food and Drug Administration division failed to sign off on their drug Waylivra.

J. Craig Venter Institute Calls for Dismissal of Lawsuit

The J. Craig Venter Institute filed a motion to dismiss a lawsuit alleging that its CEO, J. Craig Venter, took trade secrets from former employer Human Longevity.

Rakuten Aspyrian Raises $150 Million in Series C Round

Rakuten Aspyrian hauled in a $150 million Series C round as the company’s lead cancer candidate moves into a final-stage trial.

If It’s Good Enough for Illumina, Then UTC Is Good Enough for Others

BIOTECH: Genomics Giant Does Trailblazing In Real Estate, Too

Illumina keeps outgrowing its digs, which becomes evident looking at the UTC landscape.

Tease photo

Dthera Sciences Nabs FDA Breakthrough Designation

Dthera Sciences’ device intended for Alzheimer’s patients has received a breakthrough designation that will speed regulatory review.

Kane Named CEO of UC San Diego Health Physicians

Dr. Christopher Kane will lead the charge to expand primary care access, among other goals, in new roles as dean of clinical affairs for UC San Diego School of Medicine and CEO of UC San Diego Health Physicians.

Dexcom Buys TypeZero Technologies

San Diego’s Dexcom has gained additional diabetes management technology by acquiring TypeZero Technologies. Deal terms were not disclosed.

Wave of Investment Has Life Sciences Swimming in Cash

Cash is pouring into early-stage San Diego life sciences, with 2018 shaping up as a banner year, according to observers.

Tease photo

Rady Children’s Appoints New CEO

Dr. Patricio “Patrick” A. Frias has been named as the new president and CEO of Rady Children’s Hospital and Health Center.

Tri-City to Reconsider Suspension of Mental Health Unit

The Tri-City Healthcare District board will soon reconsider a decision to suspend operations of the center’s inpatient Behavioral Health Unit and Crisis Stabilization Unit.

DJO Moving to Texas, Cutting 187 Local Jobs

DEVICES: 300 Jobs to Remain; Co. Consolidating Operations

DJO Global, which grew from a garage startup to become one of North County’s largest private employers, is laying off 187 local employees and relocating its headquarters to Dallas, Texas.

Tease photo

Synthorx Hires a CMO

Joseph Leveque has joined San Diego biotech Synthorx as chief medical officer.

UC San Diego Health, Rancho Family Medical Group Enter Affiliation

Rancho Family Medical Group, or RFMG, will be able to tap into services from UC San Diego Health through a new affiliation.

Venter Retires as Chairman of Synthetic Genomics Board

J. Craig Venter has retired as chairman of the Synthetic Genomics board, according to a company news release.

Local Device Cos. See Solid Quarterly Results

MEDICINE: National Picture Expecting 4% to 5% Growth

Four major medical device companies based in San Diego recently delivered strong quarterly results, lifting their stocks and growth outlooks.

Tease photo

La Jolla Institute Researcher Lands $2.24M Grant

Ferhat Ay with the La Jolla Institute for Allergy and Immunology was awarded a $2.24 million grant to for research into genetic variation and disease risk.

Rady’s Expands Services in Riverside with New Facility

Rady Children’s Hospital-San Diego recently held a grand opening for a medical plaza in southwest Riverside County, with the dual goal of consolidating outpatient operations and reaching more patients.

Partnerships, Pipeline Put Inovio in Good Position

PHARMA: Versatile Co. Takes On Cancers, Infectious Diseases

Inovio Pharmaceuticals Inc. has about 300 employees, tenfold that of 2009. Most of the scaling up occurred in the last few years to support a growing pipeline of therapies targeting cancers and infectious diseases.

Tease photo

Illumina Continues To Exceed Expectations

In quarter two earnings, Illumina continued a streak of stomping analyst expectations.

Tease photo

Walk-In Clinics Part Of Care Providers’ Pursuit of Patients

MEDICINE: Bringing Services to the Consumer Is Trend in Health Care

Forget far-off appointments and long drives to the doctor’s office.

Tease photo

Reporter’s Notebook: Politics and Priorities Hinder Repeal of Medical Device Tax

Competing congressional priorities are clouding the path forward for an effort to kill a 2.3 percent excise tax on medical device makers, San Diego’s NuVasive and ResMed among them.

Q2: Strong Ingrezza Sales Lift Neurocrine

Neurocrine’s Ingrezza — the first treatment for the nervous system disorder tardive dyskinesia — continues to rake in revenue.

Q4: ResMed Revenue Up 12 Percent

San Diego-based ResMed listed fourth quarter revenue as $623.6 million, a 12 percent year-over-year increase.

Dexcom’s Stock Soars After Q2 Results

San Diego-based Dexcom’s stock hit $118.57 a share the morning of Aug. 2, up sharply from closing Aug. 1 at $95.44.

#2 Fastest Growing Private Company

Special Report: Fastest-Growing Private Companies

Kevin Lustig calls Scientist.com an overnight success story a dozen years in the making.

Tease photo

Q2: NuVasive Revenue Jumps 8.5%

San Diego medical device company NuVasive reported $281.6 million in second quarter earnings, an 8.5 percent year-over-year jump.

Omniome Raises $60M Round

San Diego-based Omniome, maker of a DNA sequencing platform, today announced a $60 million series B round.

ResMed, Verily Look for Insight, Reach in Data

BIOTECH: Sleep Apnea Venture to Be 50/50 Partnership

One has the data. The other has the analytics.

Tease photo

Illumina’s Q2 Revenue, Earnings Beat Expectations

Illumina in the second quarter reported revenue of $830 million, a 25 percent year-over-year increase.

Irish Drug Company Sublimity Opens Solana Beach Office

Sublimity Therapeutics, an Irish pharmaceutical in the realm of gastrointestinal and immunological diseases, has set up a Solana Beach office with six employees.

Gossamer May Give S.D. Its Flagship Biotech

PHARMA: A $230M Funding Round, Strong Leaders Are Big Pluses

By going big, Gossamer Bio looks to break the mold.

Tease photo

After Turmoil, Human Longevity Sharpens Focus on Commercialization

GENOMICS: Exec Says Co. Has Cash, Runway to Next Phase

New leadership at Human Longevity is seeking to emerge from a tumultuous period of executive exodus and workforce reduction through a bid to bring its genomics-based testing center to a wider market.

Tease photo

Mesa Biotech Picks up $20M Series B Round

Molecular diagnostic company Mesa Biotech recently notched a $20 million series B round.

A Constellation Of Health Data

Health care: Diverse Mix of Cos. Driving Patient Access to Their Records

In a maturing digital health space with an urgent need to collect disparate data, think of Seqster as something of a data locker: Patients can find health records from past caregivers, genomics reports and data from wearables like Fitbit.

Tease photo

House Votes to Repeal Medical Device Tax

The House voted July 24 to repeal a 2.3 percent excise tax on medical device makers, welcome news to San Diego’s consortium of medical device companies, including NuVasive and ResMed.

Zavante Therapeutics Acquired

Nabriva Therapeutics has acquired San Diego-based Zavante Therapeutics, known for an antibiotic to fight infections picked up in hospitals.

One Medical Expands to San Diego

One Medical, an independently held primary care practice, will open three new offices in San Diego in early 2019.

Human Longevity Lawsuit Alleges Venter Took Trade Secrets

Human Longevity, or HLI, has accused the former CEO and noted geneticist, J. Craig Venter, of stealing trade secrets.

Gossamer Bio Snags $230M, Names New CEO

Gossamer Bio’s war chest just got a whole lot bigger.

Ra Medical Readies IPO Worth up to $86.25M

Medical device company Ra Medical recently filed paperwork for an initial public offering worth up to $86.25 million.